191 related articles for article (PubMed ID: 2587199)
1. Hairy cell leukemia: follow-up after completion of alpha interferon treatment.
Castaigne S; Sigaux F; Degos L; Flandrin G
Nouv Rev Fr Hematol (1978); 1989; 31(5):321-5. PubMed ID: 2587199
[TBL] [Abstract][Full Text] [Related]
2. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
[TBL] [Abstract][Full Text] [Related]
3. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
5. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
Seymour JF; Estey EH; Keating MJ; Kurzrock R
Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
[TBL] [Abstract][Full Text] [Related]
6. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
Quesada JR; Lepe-Zuniga JL; Gutterman JU
Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
8. The UCLA experience with type I interferons in hairy cell leukemia.
Glaspy JA; Jacobs AD; Golde DW
Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
[TBL] [Abstract][Full Text] [Related]
9. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
10. [Experience in treating patients with hairy-cell leukemia with a Soviet genetically engineered interferon].
Lepkov SV; Kruglova GV; Volkova MA; Demina EA
Ter Arkh; 1989; 61(7):133-6. PubMed ID: 2588131
[No Abstract] [Full Text] [Related]
11. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
[TBL] [Abstract][Full Text] [Related]
12. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
13. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
Flandrin G; Castaigne S; Sigaux F; Degos L
Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
[TBL] [Abstract][Full Text] [Related]
14. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alpha-2A.
Lishner M; Lang R
Blood; 1990 Sep; 76(5):1055. PubMed ID: 2393713
[No Abstract] [Full Text] [Related]
15. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
16. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
[TBL] [Abstract][Full Text] [Related]
17. Oculomotor nerve paralysis induced by alpha II-interferon.
Bauherz G; Soeur M; Lustman F
Acta Neurol Belg; 1990; 90(2):111-4. PubMed ID: 2114727
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
[TBL] [Abstract][Full Text] [Related]
20. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
Thompson JA; Brady J; Kidd P; Fefer A
Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
